Authors:
Tazoe, S
Masuda-Kato, T
Chikama, Y
Aisaka, K
Citation: S. Tazoe et al., Determination of 1,5-anhydro-D-glucitol on the basis of its inhibitory effect on trehalase activity, J BIOSCI BI, 92(2), 2001, pp. 186-188
Authors:
Kaibara, M
Watanabe, T
Ooka, F
Liang, SG
Aisaka, K
Okinaga, S
Citation: M. Kaibara et al., Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer, CL HEMORH M, 24(2), 2001, pp. 93-99
Authors:
Ono, R
Kobayashi, S
Wagatsuma, H
Aisaka, K
Kohda, T
Kaneko-Ishino, T
Ishino, F
Citation: R. Ono et al., A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21, GENOMICS, 73(2), 2001, pp. 232-237
Authors:
Hayashi, M
Hamada, A
Okaya, Y
Wakitani, K
Aisaka, K
Citation: M. Hayashi et al., Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factorXa in vitro and in vivo, EUR J PHARM, 428(2), 2001, pp. 163-168
Authors:
Hayashi, M
Matsuo, A
Nakamoto, H
Aisaka, K
Citation: M. Hayashi et al., Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals, EUR J PHARM, 412(1), 2001, pp. 61-66
Authors:
Miyoshi, N
Wagatsuma, H
Wakana, S
Shiroishi, T
Nomura, M
Aisaka, K
Kohda, T
Surani, MA
Kaneko-Ishino, T
Ishino, F
Citation: N. Miyoshi et al., Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q, GENES CELLS, 5(3), 2000, pp. 211-220
Authors:
Kobayashi, S
Wagatsuma, H
Ono, R
Ichikawa, H
Yamazaki, M
Tashiro, H
Aisaka, K
Miyoshi, N
Kohda, T
Ogura, A
Ohki, M
Kaneko-Ishino, T
Ishino, F
Citation: S. Kobayashi et al., Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3, GENES CELLS, 5(12), 2000, pp. 1029-1037
Authors:
Ahmed, H
Moriyama, N
Fukasawa, R
Nishimatsu, H
Tanaka, Y
Kitamura, T
Tatemichi, S
Akiyama, K
Suzuki, Y
Aisaka, K
Citation: H. Ahmed et al., Contractile properties of urethral smooth muscles of young and aged femaledogs: Morphological and pharmacological aspects, INT J UROL, 7(8), 2000, pp. 298-306
Authors:
Yamada, S
Okura, T
Kimura, R
Deguchi, Y
Suzuki, Y
Kobayashi, T
Aisaka, K
Citation: S. Yamada et al., Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues, DRUG META D, 28(12), 2000, pp. 1487-1492
Authors:
Suzuki, Y
Moriyama, N
Okaya, Y
Kanada, A
Nishimatsu, H
Kawabe, K
Aisaka, K
Citation: Y. Suzuki et al., Distribution of alpha(1L)-adrenoceptors in canine prostate: Characterization by quantitative autoradiography, J PHARM PHA, 52(6), 2000, pp. 653-657
Authors:
Okutsu, T
Kuroiwa, Y
Kagitani, F
Kai, M
Aisaka, K
Tsutsumi, O
Kaneko, Y
Yokomori, K
Surani, MA
Kohda, T
Kaneko-Ishino, T
Ishino, F
Citation: T. Okutsu et al., Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors, J BIOCHEM, 127(3), 2000, pp. 475-483
Citation: Y. Suzuki et al., Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on prostate function in dogs, EUR J PHARM, 394(1), 2000, pp. 123-130
Citation: Y. Hirata et al., Cardiovascular pharmacological studies on JTV-506, a new potassium channelopener 2nd communication: Effects on blood pressure in conscious animals, ARZNEI-FOR, 50(4), 2000, pp. E333-E340
Citation: Y. Hirata et al., Cardiovascular pharmacological studies on JTV-506, a new potassium channelopener - 1st communication: Effects on myocardium and vasculature, ARZNEI-FOR, 50(3), 2000, pp. E236-E243
Authors:
Ohkura, T
Yamada, S
Tohma, A
Kimura, R
Aisaka, K
Citation: T. Ohkura et al., Ex vivo and in vivo alpha(1)-adrenoceptor binding characteristics of a novel alpha(1L)-adrenoceptor antagonist, JTH-601, in rat tissues, BIOL PHAR B, 22(7), 1999, pp. 687-690
Authors:
Suzuki, Y
Moriyama, N
Okaya, Y
Nishimatsu, H
Kawabe, K
Aisaka, K
Citation: Y. Suzuki et al., Age-related change of the role of alpha(1L)-adrenoceptor in canine urethral smooth muscle, GEN PHARM, 33(4), 1999, pp. 347-354
Authors:
Suzuki, Y
Moriyama, N
Kanada, A
Okaya, Y
Kawabe, K
Aisaka, K
Citation: Y. Suzuki et al., The role of alpha(1L)-adrenoceptor in rat urinary bladder: Comparison between young adult and aged rats, LIFE SCI, 65(24), 1999, pp. 2553-2559
Authors:
Suzuki, Y
Kanada, A
Okaya, Y
Aisaka, K
Muramatsu, I
Citation: Y. Suzuki et al., Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure, EUR J PHARM, 374(3), 1999, pp. 495-502
Authors:
Hirata, Y
Kanada, A
Miyai, H
Mabuchi, Y
Aisaka, K
Citation: Y. Hirata et al., Effects of the new potassium channel opener JTV-506 on coronary vessels invitro and in vivo, ARZNEI-FOR, 49(3), 1999, pp. 199-206
Authors:
Kaibara, M
Mitsuhashi, Y
Watanabe, T
Tamiaki, F
Nishihara, M
Sadatsuki, M
Aisaka, K
Citation: M. Kaibara et al., Effects of red blood cells on the coagulation of blood in normal and preeclamptic pregnancies, AM J OBST G, 180(2), 1999, pp. 402-405
Authors:
Aisaka, K
Uesato, T
Miwa, A
Ogawa, M
Tamiaki, F
Koshino, T
Nishihira, M
Liang, SG
Kaibara, M
Citation: K. Aisaka et al., Evaluation of vitamin K2 (menatetrenone) administration with hormone replacement therapy on prevention of osteoporosis in climateric women, 9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, pp. 79-83